Skip to Content
Is it Exocrine Pancreatic Insufficiency? Get more info

Flutemetamol f-18 Pregnancy and Breastfeeding Warnings

Flutemetamol f-18 is also known as: Vizamyl

Flutemetamol f-18 Pregnancy Warnings

Use of flutemetamol F-18 is not recommended unless clearly needed. FDA pregnancy category: C

Animal studies have not been conducted with flutemetamol F-18. There are no controlled data in human pregnancy. All radiopharmaceuticals have the potential to cause fetal harm. The risk of fetal harm is dependent on the stage of fetal development, and the magnitude of the dose. Flutemetamol F-18 should be administered to a pregnant woman only if clearly needed. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Flutemetamol f-18 Breastfeeding Warnings

Avoid use if breastfeeding, or have the mother temporarily interrupt breastfeeding for 24 hours (greater than 10 half-lives of radioactive decay for the F-18 isotope) after exposure to flutemetamol F-18. If breastfeeding is interrupted, the patient should pump and discard her breast milk and use alternate infant nutrition sources (e.g., stored breast milk or infant formula) for 24 hours after administration of the drug.

Breastfeeding is not recommended during use of flutemetamol F-18. Excreted into human milk: Unknown Excreted into animal milk: Data not available The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Vizamyl (flutemetamol F-18)." GE Healthcare, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Vizamyl (flutemetamol F-18)." GE Healthcare, Princeton, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide